The inspection of the first four batches of the domestic COVID-19 vaccine has been completed and the doses are ready to be rolled out, the Food and Drug Administration (FDA) said yesterday.
The inspection of the four batches of the vaccine made by Medigen Vaccine Biologics Corp (高端疫苗), a total of 265,528 doses, was completed on Friday last week and they are being sealed at a designated warehouse in preparation for use, FDA Research and Inspection Division head Wang Teh-yuan (王德原) said.
The sealing was expected to be completed yesterday evening, he said.
Photo courtesy of the Food and Drug Administration
The Medigen vaccine, the first protein-based COVID-19 vaccine to be made available in Taiwan, would be good for six months before they expire, he added.
Medigen secured an emergency use authorization (EUA) for the vaccine from the FDA on July 19.
It took the FDA about one month to carry out the inspection of the first four batches of the protein-based vaccine, which is different from the spike-protein-based AstraZeneca vaccine and the mRNA-based Moderna vaccine previously received from overseas, Wang said, adding that the inspection took longer than the other two vaccines, including 21 days in animal testing to ensure its efficacy.
The Central Epidemic Command Center said that the Medigen vaccine would be offered in the national vaccination program when there is a sufficient number of doses.
Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said it would be difficult to distribute the vaccine when there are so few doses available, adding that the center would wait until about 500,000 to 600,000 doses have passed testing before offering it in the program.
Asked whether the Medigen vaccine went into mass production and lot release testing before it received an EUA, Chen said that the EUA would not have been issued just because the product had gone into mass production, adding that when facing a pandemic, some vaccine development steps were conducted in parallel without increasing the risk for study participants to accelerate its development.
The center had requested that the Medigen vaccine go into mass production prior to the EUA review, Chen said, adding that according to the procurement agreement signed with the company, if the vaccine had failed to obtain an EUA then production costs would have been paid by the center.
Asked why the lot numbers of the four batches that passed testing were not sequential, Chen said that some of the batches still have problems that need to be solved, such as lacking the required technical information for review.
Meanwhile, Chen said that as the number of doses of the AstraZeneca vaccine is running short, the center plans to offer doses of the Moderna vaccine in the next round of bookings.
After 140,000 Moderna doses had been reserved for the second jabs of people in the top three priority groups, pregnant women and people aged 65 or older, there would be about 420,000 doses offered to other people who have registered on the national vaccination booking system, he said.
Eligible recipients of the Moderna vaccine in the next round would mainly be people in the ninth priority group of people who have a high-risk disease, a rare disease or catastrophic illness, he added.
There are about 880,000 people in the ninth priority group who only selected the Moderna vaccine, Chen said.
PREPAREDNESS: Given the difficulty of importing ammunition during wartime, the Ministry of National Defense said it would prioritize ‘coproduction’ partnerships A newly formed unit of the Marine Corps tasked with land-based security operations has recently replaced its aging, domestically produced rifles with more advanced, US-made M4A1 rifles, a source said yesterday. The unnamed source familiar with the matter said the First Security Battalion of the Marine Corps’ Air Defense and Base Guard Group has replaced its older T65K2 rifles, which have been in service since the late 1980s, with the newly received M4A1s. The source did not say exactly when the upgrade took place or how many M4A1s were issued to the battalion. The confirmation came after Chinese-language media reported
A Ministry of Foreign Affairs official yesterday said that a delegation that visited China for an APEC meeting did not receive any kind of treatment that downgraded Taiwan’s sovereignty. Department of International Organizations Director-General Jonathan Sun (孫儉元) said that he and a group of ministry officials visited Shenzhen, China, to attend the APEC Informal Senior Officials’ Meeting last month. The trip went “smoothly and safely” for all Taiwanese delegates, as the Chinese side arranged the trip in accordance with long-standing practices, Sun said at the ministry’s weekly briefing. The Taiwanese group did not encounter any political suppression, he said. Sun made the remarks when
The Taiwanese passport ranked 33rd in a global listing of passports by convenience this month, rising three places from last month’s ranking, but matching its position in January last year. The Henley Passport Index, an international ranking of passports by the number of designations its holder can travel to without a visa, showed that the Taiwan passport enables holders to travel to 139 countries and territories without a visa. Singapore’s passport was ranked the most powerful with visa-free access to 192 destinations out of 227, according to the index published on Tuesday by UK-based migration investment consultancy firm Henley and Partners. Japan’s and
BROAD AGREEMENT: The two are nearing a trade deal to reduce Taiwan’s tariff to 15% and a commitment for TSMC to build five more fabs, a ‘New York Times’ report said Taiwan and the US have reached a broad consensus on a trade deal, the Executive Yuan’s Office of Trade Negotiations said yesterday, after a report said that Washington is set to reduce Taiwan’s tariff rate to 15 percent. The New York Times on Monday reported that the two nations are nearing a trade deal to reduce Taiwan’s tariff rate to 15 percent and commit Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) to building at least five more facilities in the US. “The agreement, which has been under negotiation for months, is being legally scrubbed and could be announced this month,” the paper said,
RSS